Pacira Pharmaceuticals, Inc. (PCRX)

Company Description

Pacira Pharmaceuticals is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the US in April 2012. EXPAREL and two other products have utilized the PCRX proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

 

COMPANY ADDRESS
5 Sylvan Way
Parsippany, NJ 07054
United States

COMPANY PHONE
973-254 3560

COMPANY WEBSITE



Get BioInvest's perspective on Pacira's CEO


Latest Company News

Ranking Shares of Pacira Pharmaceuticals, Inc. (NasdaqGS:PCRX): How do They ... Geneva Journal - 1 hour ago The Piotroski F-Score is a scoring system between 1-9 that determines a firm's financial strength. The score helps determine if a company's stock is valuable or not. [...]
Tue, Jun 27, 2017 8:37:00 PM, Continue reading at the source
Share Activity Lifted for Pacira Pharmaceuticals Inc (PCRX) in Session Evergreen Caller - 5 hours ago Needle moving action has been spotted in Pacira Pharmaceuticals Inc (PCRX) as shares are moving today on volatility -0.74% or -0.35 from the open. Alyeska Investment Group LP Raised By $16.04 Million Its Pacira ... - Wolcott Daily Pacira Pharmaceuticals, Inc. (PCRX) Stock Rating Reaffirmed by Wedbush - Markets Daily [...]
Tue, Jun 27, 2017 5:19:00 PM, Continue reading at the source
Option Market Alert: Pacira Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Jun 23, 2017 No Risk Alert Here: Before we dive into any analysis we simply note that Pacira Pharmaceuticals Inc (NASDAQ:PCRX) risk is neither elevated nor depressed. Pacira Pharmaceuticals, Inc. (PCRX) Lifted to “Hold” at ValuEngine - The Cerbat Gem Analyst Recommendations And Earnings Forecast: Pacira Pharmaceuticals, Inc ... - Post Analyst [...]
Fri, Jun 23, 2017 4:52:00 PM, Continue reading at the source
The Secret to Option Trading Right Before Earnings in Pacira Pharmaceuticals Inc CML News - Jun 22, 2017 There is a wonderful secret to trading options right before earnings announcements in Pacira Pharmaceuticals Inc (NASDAQ:PCRX) , and really many stocks, that benefits from the rising implied volatility but avoids the risk into the actual earnings ... [...]
Thu, Jun 22, 2017 6:45:00 PM, Continue reading at the source
Pacira Pharmaceuticals Inc. (PCRX) Soars 7.69% on June 21 Equities.com - Jun 21, 2017 Pacira Pharmaceuticals Inc. (PCRX) had a good day on the market for Wednesday June 21 as shares jumped 7.69% to close at $46.90. Pacira Pharmaceuticals, Inc. (PCRX) Position Decreased by Suffolk Capital ... - The Cerbat Gem The Pacira Pharmaceuticals, Inc. (PCRX) Position Reduced by Denver Investment ... - BangaloreWeekly [...]
Wed, Jun 21, 2017 9:22:00 PM, Continue reading at the source
Option Trading: Pacira Pharmaceuticals Inc Long Put Spreads and Understanding ... CML News - Jun 19, 2017 As we look at Pacira Pharmaceuticals Inc we note that a long put spread is one of the most common implementations of an option strategy during a bull market, but the analysis completed when employing the long put spread often times lacks the necessary ... [...]
Mon, Jun 19, 2017 4:07:00 PM, Continue reading at the source
Pacira Pharmaceuticals Appoints Mark I. Froimson, MD, to Board of Directors GlobeNewswire (press release) - Jun 15, 2017 PARSIPPANY, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced the appointment of Mark I. Froimson, M.D. Form 8-K Pacira Pharmaceuticals, For: Jun 13 - StreetInsider.com [...]
Thu, Jun 15, 2017 11:26:00 AM, Continue reading at the source
Trading Options During Earnings in Pacira Pharmaceuticals Inc CML News - Jun 9, 2017 We're going to examine buying and selling out of the money strangles in Pacira Pharmaceuticals Inc and find out once and for all what the winning trades have been during earnings releases. [...]
Fri, Jun 09, 2017 4:41:00 PM, Continue reading at the source
Pacira Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare ... Nasdaq - Jun 1, 2017 PARSIPPANY, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that members of its management team are scheduled to present at the Jefferies 2017 Global Healthcare Conference at 1:30 PM ET ... [...]
Thu, Jun 01, 2017 11:26:00 AM, Continue reading at the source
Why Investors remained buoyant on: Pacira Pharmaceuticals, Inc. (PCRX), First ... StockNewsJournal - May 29, 2017 Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) market capitalization at present is $1.82B at the rate of $45.15 a share. An End-of-Day Technical Review: Pacira Pharmaceuticals, Inc. (PCRX), T. Rowe ... - Post Analyst Pacira Pharmaceuticals Incorporated (NASDAQ:PCRX) Short Interest Decreased By ... - KL Daily [...]
Mon, May 29, 2017 11:15:00 AM, Continue reading at the source